html Omega-3, joints and mobility | Omega-3 Science
Content based on scientific studies and verifiable data.Updated: September 2026
Joints and mobility

Omega-3 and joints: pain, mobility and function

EPA and DHA influence eicosanoids and inflammatory pathways involved in joint pain and stiffness. Meta-analyses of randomized trials show measurable benefits in rheumatoid arthritis and osteoarthritis.

Key benefits

Four clinical outcomes that matter

↓

Joint pain

Meta-analyses found fewer painful joints and an average reduction in pain.

↔

Mobility

In osteoarthritis, function and mobility improved in pooled analyses of RCTs.

Rx

Lower NSAID use

In rheumatoid arthritis, longer studies showed a lower need for non-steroidal anti-inflammatory drugs.

6:3

Lipid profile

Trials in rheumatoid arthritis confirmed higher EPA/DHA and a lower omega-6:3 ratio alongside clinical outcomes.

Pain and mobility should also be considered in the context of chronic low-grade inflammation. If you train, also see omega-3 and athletes; to preserve independence over the years, see longevity and older adults.

Rheumatoid arthritis

18 randomized trials, 1,018 participants

A recent meta-analysis assessed biomarkers and joint symptoms.

EPA+DHA ↑

Supplementation increased EPA and DHA incorporation.

Ratio 6:3 ↓

The fatty-acid balance shifted in a more favorable direction.

Painful joints ↓

The number of painful joints decreased, with an approximate SMD of −0,59.

PMID 38922552 →Related scientific study
Osteoartrite

Pain and function improved in meta-analysis

Nine randomized trials included 2,070 people with osteoarthritis.

Pain

Average pain reduction with SMD −0,29.

Function

Functional improvement with SMD −0,21.

2.070 participants

The effect was observed across the included trials.

PMID 37226250 →Related scientific study